Regional and national databases of routinely collected data contain large quantities of health information, usually covering whole populations and often spanning prolonged time periods. Using routine data involves identifying useful sources, assessing the quality of the data and deciding whether what is available is 'fit for purpose'. As long as adequate care is taken, these data may be used in a number of different ways beyond their traditional uses for population health assessments and health service planning.
Introduction
Routinely collected data held in national and regional databases form a valuable and sometimes neglected source of information. Some examples of routine data are as follows: vital statisticsdeaths, births, stillbirths; cancer registry data; hospital episode data; national immunization records; statutory notifications of infectious diseases; abortion notifications; and microbiology laboratories' data compiled centrally by national communicable disease surveillance organizations. This paper describes some of the uses of routine data, and discusses the issues that should be considered when thinking of using such data.
Uses of routine data

Population health assessments
Public health surveillance, and assessments of the health of a population are usually based on routine data, particularly communicable disease notifications and disease-specific mortality information. One of the earliest studies to use such data was Graunt's elegant analysis of the 'Bills of Mortality' which were produced in London during the Plague. 1 Data which include postcode of residence, or some other means of geographical referencing at small area level, lend themselves to the investigation of putative clusters of disease.
Clinical audit studies
Routine data are theoretically well suited to clinical audit studies. 2 One of the most difficult and expensive parts of the audit cycle is the collection of accurate data, and the continuation of such data collection in the same way after changes in practice have been made -yet it is only by doing this that the audit loop can be closed. Data which are being collected routinely are therefore very convenient, as long as they are adequate for the study. They may be used to identify a case listing for retrospective audit (by going back to the case notes for validation and abstraction of additional data) or for cross-checking the completeness of prospective audits.
Evaluation of interventions at a population level
Information from national and regional databases can be used to evaluate the impact of certain interventions. Obviously, routine data can never take the place of properly conducted randomized controlled trials. However, it is also important to assess whether advances demonstrated in randomized controlled trials are translated into benefit in routine practice. For example, Black et al. 3 have demonstrated enhanced survival from testicular cancer over time presumably consequent upon improvements in therapy.
Analytical epidemiological studies
The potential value of routine data for analytical epidemiological studies (as opposed to descriptive studies) is often ignored. With some imagination, the wealth of data held in national and regional databases may be usefully exploited in many different ways. The data may be used for cohort and casecontrol studies. 4 
"
6 They may also be used as a platform for further studies. For example, routine data may be used as a base for recruitment into randomized controlled trials. 7 Record linkage (see below) may facilitate follow-up studies -for example, through linkage of two separate national or regional databases, or linkage of a research dataset to a national or regional database to permit follow-up for hospital admissions and deaths. 
Planning and commissioning
One of the main traditional uses of information derived from routine data is within the area of planning and commissioning. Information may be used as a basis for needs assessment work by giving a statistical profile of existing activity, and allowing predictions of likely future changes. The data can also be used to monitor the effects of changes in service provision.
Advantages of using routine data
There are particular advantages of using routine data, which are summarized as follows:
(1) Relatively low cost -because the structures for collecting routine data already exist, the cost of using data from national and regional databases usually relates only to analysis. (2) Size of the database -the large numbers of records in national and regional databases reduce the problems of sampling errors and reduce the likelihood of selection bias. (3) Population coverage -routine data usually cover a whole population rather than a sample. Incidence and prevalence calculated from a whole population are exact and need no confidence intervals (although if such data are used to estimate risk, it is not unreasonable to assume that they are a sample of some undefined larger population, and to calculate the relevant confidence limits). (4) Time period coverage -routine data often span a prolonged period of time, allowing trends to be discerned.
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(5) Breadth and diversity -most databases have many and diverse recorded items. This allows researchers to explore unexpected avenues. Care must be taken, however, not to 'dredge' the data for associations which have no prior hypothesis or biological basis.
Identification of potentially useful routine data
The first step in using routine data for a planned project or study is the identification of useful national or regional databases containing relevant data. This involves asking three main questions, as follows.
(1) What potentially useful databases are available?
Perhaps the hardest task is finding out what data are available, and who holds them. The best starting point is reading published papers and talking to colleagues. For most healthrelated data, it is worth contacting the large national organizations that hold routine data (Table 1) . These organizations will usually point enquirers in the right direction if they do not hold the information themselves. Unless the requirements for data are very simple, it is worth while discussing specific requests with the holders of the data. They may be aware of particular potential problems (and their solutions), or of similar requests in the recent past.
(2) Which data items are available in the database(s)?
The data items collected in each potentially useful database need to be examined. If some vital information for the required project is missing then a database may be excluded at this stage. It is, however, important to remember that additional data items can be derived or calculated from the available data items; for example, deprivation index can be derived from postcode of residence, or survival following cancer diagnosis can be calculated based on linked cancer registration and mortality data. Many large national and regional databases collect clinical information using some sort of coding system (for example, ICD9 10 and ICD10 11 for diagnostic information, OPCS4 12 for procedural information). The particular coding system being used should also be examined to see if it provides sufficient discrimination and detail for the proposed project. Alternative ways of using routine data should be considered. Flagging of cases at the National Health Service Central Register (NHSCR) allows mortality and cancer registration information to be collected for any specified group of individuals. This is particularly useful for prolonged follow-up of large cohorts.
At a more sophisticated level, record linkage may be used to pull together records belonging to the same individual. This may involve linkage of two or more national or regional datasets or linkage of a research dataset to a national or regional dataset. This may be used to provide follow-up information for a group of patients or to add additional data to a research database. In particular, ISD Scotland and the Record Linkage System in Oxford have the facilities and expertise to perform complex record linkages using probability matching. This method of linkage allows for imperfections in the identifying information in the records to be linked and matches records belonging to the same individual with an accuracy of over 98 per cent. 13 
Confidentiality and privacy issues
It is important to consider issues of patient confidentiality and privacy at an early stage. This will affect data availability and the way that data may be used (see below for further discussion).
Data quality
The quality of routine data will often determine their usefulness. Various factors can contribute to data quality, including systematic training of clinical coders, use of unambiguous definitions 2 , well-defined procedures relating to data collection and an active programme of quality assurance which incorporates feedback to those responsible for data collection.
14 When potentially useful routine data have been identified, there are several specific aspects to think about concerning data quality, as follows.
(1) How complete are the data?
Completeness of ascertainment
Completeness of ascertainment is the extent to which every case has been captured by the data collection mechanism. It is not always possible to disentangle this from data accuracy. For example, although it may be possible to say that almost 100 per cent of deaths are ascertained, the completeness of mortality data relating to a particular disease will depend on the accuracy of the diagnosis and the way in which the death certificate is completed and interpreted. Statutory returns do not guarantee complete ascertainment. Even for a condition as serious as meningococcal disease, notifications may account for less than 70 per cent of cases. 15 Completeness is likely to be higher if multiple sources of ascertainment are used, although this also increases the risk of duplicate records. In Scotland, for example, ascertainment of diagnosed cases of cancer probably exceeds 95 per cent for many sites. 16 Depending on the database, there are various methods of assessing the completeness of ascertainment. These include comparisons with historic data or independent sources of equivalent data, including, where appropriate, capture-recapture methods. 17 To allow a judgement about the validity of such comparisons, it is essential to consider whether the same inclusion criteria, definitions and classification or coding systems apply to each of the databases being compared.
Completeness of recording
Completeness of recording is the extent to which each data item relating to a single record is recorded. This is easily measurable and is usually expressed as a proportion (for example, the percentage of cases whose postcode of residence was recorded).
(2) How accurate are the data?
Accuracy or validity is the extent to which the data reflect reality usually measured against a 'gold standard'. (Validity has several meanings. Within this paper the meaning is 'the degree to which a measurement measures what it purports to measure'. 18 ) Sometimes the term accuracy is used in an allencompassing sense to reflect high quality of data in every aspect; sometimes the term is simply applied to each field of data without considering the implications of other aspects of data quality such as completeness of ascertainment.
A detailed assessment of data accuracy will usually involve individual records. This may take the form of a comparison against information re-abstracted from the original source document, for example, medical records 14 ' 19 , alternatively, it may involve comparison against what might be regarded as a 'true gold standard', for example, validation of death certificate diagnoses by autopsy. 20 Re-abstraction of information from source documents may be viewed as simply measuring reliability (consistency with the previous observation) rather than accuracy. 21 However, there would appear to be little point in measuring reliability unless it is believed to reflect the accuracy of the data.
(3) How timely are the data?
Prompt exchange of information is important in the context of the clinical care of individual patients. The availability of contemporary aggregated data is also desirable but, at least for chronic diseases, immediacy may be more important to managers than to clinicians or epidemiologists. Indeed, some clinicians have observed that there may be a trade-off between timeliness and accuracy. 22 
Information on data quality
Information on data quality and documentation of data definitions and procedures for data collection will often be available from the organizations that hold the national databases. Independent assessments of data quality for specific types of routine data are also often available in the literature. 14 25 Informed assessments of data quality should take into account the relevance of any errors, within the context of what the data are to be used for. For example, errors in the terminal digit of the postcode may be of little importance, whereas major errors in diagnostic coding may be crucial.
The role of clinicians in improving data quality
The quality of routine data is often criticized. Sometimes this is entirely justifiable but sometimes it is based on historic prejudices or reflects ignorance of the purpose and uses of routine data. Although some studies have suggested that diagnostic data are of poor quality, others have demonstrated that very high accuracy can be achieved.
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' 25 In Scotland there is evidence that the quality of hospital discharge data has improved substantially in recent years.
14 In general, data items which are recorded simply, such as dates of admission, are very accurate. Data items which are more complex and need to be coded from text, such as an operation code, are more likely to cause problems.
Ironically, the most vociferous critics of routine data apparently fail to recognize that they themselves are (directly or indirectly) responsible for the quality of those data. Clerical staff or statisticians cannot be held responsible for ambiguities and inconsistencies in medical records. 26 Likewise, they are not to blame for doctors' lack of knowledge about infectious disease notification 27 or death certification. 28 The underlying problem is a lack of education for medical professionals. Unfortunately, it is difficult to make routine data collection seem exciting and a high priority for students and teachers alike. However, given the substantial investment in collection of routine data, it seems short-sighted not to make every effort to maximize their quality.
Are the routine data fit for purpose?
Whether routine data are fit for purpose for a planned study will depend mainly on the adequacy of the available data items and the quality of the data. It may be that the data are not adequate on their own, but may form a valuable base with which other data can be combined. Such other data may be from other routinely collected sources. For instance, in studies of meningococcal infection, data from infectious disease notifications may be combined with laboratory data and hospital admission data. 15 Neither of these sources is likely to be adequate alone, but the combination will probably give a fairly complete picture.
Data analysis and interpretation
Ready prepared detailed analysis or disaggregated data
The central organizations which hold the data can generally provide ready prepared detailed analyses, or disaggregated data for researchers to analyse themselves. The latter solution has much greater flexibility, but depends on the availability of the right hardware, software and skills. It is probably simplest to request data in the form of a 'flat file' database format, requesting only the fields that are likely to be needed. File size can be further reduced by asking for partially aggregated data, for instance, using five-year age bands rather than single years. Availability of disaggregated data will be restricted if it makes possible the identification of individuals. Partially aggregating the data may provide adequate anonymization.
In the current environment, researchers should also be prepared to pay for the analysis of the data. Such costs should always be considered when formulating a research proposal.
Mainframe or PC based analysis
Complex analyses may require the power of a mainframe computer. These are often best done by the organization that holds the database. It is essential that the required analyses are accurately described to the programmers, and specialist help will usually be needed. However, modern personal computers (perhaps operating as part of a network) and associated software are capable of analysing surprisingly large databases within a reasonable time. Using a personal computer is valuable in that it encourages the researcher to manipulate the data himself or herself and may promote a better understanding.
Standard database or statistical packages are probably the most useful. These include Epi Info and SPSS. Many people have gained their analytical experience with spreadsheets such as Microsoft Excel, and these are often satisfactory as long as the number of records is not too large.
The type of analysis depends on the type of study, but some general observations can be made. As with most studies, the novice is strongly advised to seek the advice of an experienced medical statistician.
Because of the size and completeness of most routine databases, much useful information can be gleaned from simple statistical analyses. Complex regression models are less likely to be needed, and straightforward techniques such as direct and indirect standardizations may be particularly useful.
Interpretation of the results
As with all studies, to interpret the results requires an assessment of whether the data produced are a reasonable representation of the truth. This requires an understanding of the likely effects of such factors as chance, bias and confounding. The assessment of chance and confounding are no different for routine data than for other studies, but the assessment of potential biases requires a comprehensive knowledge of the strengths and weaknesses of the data. Much of this will already have been considered when examining data quality and fitness for purpose. Artefacts caused by such factors as changes in definitions, coding or collection methods which have occurred over the period of study, or across geographical boundaries, must also be considered. For example, in 1984 in England and Wales, the Office of Population Censuses and Surveys introduced a revised interpretation of the World Health Organization's Rule 3, which governs how information in Part I and Part II of the death certificate is used to determine the underlying cause of death. 29 As a result, there was a large decrease in deaths from causes such as pneumonia in 1984, and deaths from causes often mentioned in Part II of the death certificate increased. 30 Systematic biases in the data, such as the progressive inaccuracy of cause of death with age also occur. 31 When interpreting UK data, it is also important to remember that differences do exist between the component countries. For example, the revised interpretation of Rule 3 for death certificates mentioned above was not adopted in Scotland or Northern Ireland. Similarly, between the countries of the United Kingdom, there are variations in the legal practices relating to the handling of accidental and violent death. These may lead to differences in the way in which death certificates are completed, and hence distort comparisons of certain diagnosis-specific death rates.
Confidentiality and ethical issues
Confidentiality considerations
In general, information from national databases is only disclosed in an anonymized form (i.e. with all identifying information such as name, address, postcode, National Health Service number and so on removed). Such anonymized data will be sufficient for the majority of studies. However, circumstances do arise where patient identifiable data are required, for example, if the clinical information is to be verified by comparison with case notes, the proposed study involves directly contacting individuals, or record linkage is being used to provide follow-up information. All those who handle personally identifiable data (which includes those who collect, collate, release or make use of the data) have an obligation to ensure that privacy is not endangered. The holders of the national databases have different procedures which restrict the release of patient-identifiable information to varying extents. All information held on a computer system is subject to the Data Protection Act 1984. This places restrictions on central organizations relating to the release of information and it also places obligations on all those who use the personal data. If personally identifiable information are to be released, those requesting the data have to clearly demonstrate to the data custodians that patient-identifiable data are absolutely necessary and that the proposed use of the data is of value. Research involving release of patient identifiable data from national databases will nearly always require Local Research Ethics Committee approval. Research that involves linkage of personal records from different sources may raise additional issues relating to privacy. As in all studies, individual consent must always be sought for studies which involve direct contact with the individual and for studies which specifically involve the health care being given. Any published findings must not identify patients without their specific agreement.
General ethical considerations
As with any data, however collected, anyone using or quoting routine data has an ethical duty to present them objectively and honestly with caveats attached and without over-interpretation which might distort service provision or generate spurious public alarm. The ethical dimension to this has been recently brought into focus by the publication of clinical outcome indicators derived from routinely collected data in Scotland. 32 
Conclusions
Routinely collected data provide a valuable and often underused source of information. With some imagination, and as long as adequate care is taken, the potential uses of routine data go far beyond the limited applications with which they are traditionally associated.
